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Abstract 
An assay was developed to measure and directly compare transport of doxoruhicin across right-side-out cytoplasmic membrane 
vesicles (ROV) and across model membranes (LUVET) composed of pure phospholipids, isolated from the corresponding cells. 
Escherichia coil was used as a model organism, since mutants are available which differ in phospholipid composition. Both in LUVET 
and ROV only passive diffusion across the bilayer is involved, because effects of drug concentration, pH, divalent cations, the 
phospholipid composition, and the active transport inhibitor verapamil were comparable. Permeability coefficients were about 2-3-times 
higher in ROV compared to LUVET. Furthermore, in LUVET an average activation energy of 87 kJ/mol and in ROV of 50 kJ/mol was 
observed. These differences are suggested toresult from differences in membrane order between LUVET and ROV and differences in the 
temperature d pendence of membrane order in LUVET and ROV, respectively. Because no background carrier-facilitated doxorubicin 
transport seems to be present, ROV are an excellent model system to study the effect of phospholipid composition on drug transport after 
expression of a multidrug resistance-conferring protein. Furthermore, data of passive diffusion of doxorubicin obtained with LUVET are 
representative for more complex, biologically relevant membrane systems. 
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1. Int roduct ion diffusion across the plasma membrane of the uncharged 
form of the drug which is a weak base with a pK  a of 
Doxorubicin is a potent and widely applied anti-cancer 8.3[4-7]. In order to improve drug uptake it is therefore 
drug exhibiting effects on DNA and DNA associated important o gain insight about the parameters that govern 
enzymes [1,2] as well as on membranes (for a review, see the rate of passive diffusion, such as the phospholipid 
[3]), The main route of entry into a cancer cell is passive composition and drug binding and insertion into the mem- 
branes [81. 
Until now studies including passive diffusion of dox- 
Abbreviations: CL, cardiolipin; EGTA, ethyleneglycol bis( r- orubicin involved either model systems composed of large 
aminoethyl ether)-N,N,N',N'-tetraacetic acid; Hepes, N-2-hydroxyethyl- unilamellar phospholipid vesicles [5,7,9-11] or intact cells 
piperazine-N'-2-ethanesulfonic acid; IPTG, isopropylthiogalactoside; LU- [4,12-16] and only few studies have been performed with 
VET, large unilamellar vesicles prepared by extrusion; mdr, multidrug plasma membrane vesicles [17,18]. The large unilamellar 
resistance; P, permeabilty coefficient doxorubicin; p0 permeability co- 
efficient for uncharged oxorubicin; PA, phosphatidic a id; PE, phos- vesicles (LUVET) system allows for detailed characteriza- 
phafidylethanolamine; PG, phosphatidylglycerol; Pi, inorganic phosphate; tion of the mechanism and kinetics of uptake of doxoru- 
Pipes, 1,4-piperazinediethanesulfonic acid; ROV, right-side-out cytoplas- bicin, whereas results obtained from mechanistic and ki- 
mic membrane v sicles; TLE, total ipid extract, netic studies in intact cells are much more difficult to 
* Corresponding author. Fax: +31 30 22522478; e-mail: 
dekruijff@chem.ruu.nl, interpret, because of the presence of many intracellular 
Present address: ATO-DLO, P.O. Box 17, 6700 AA Wageningen, membranes and metabolism. To what extent the data ob- 
The Netherlands. rained with the use of model membranes are representative 
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tO the in vivo situation is not clear, since a direct compari- 2.3. Isolation and determination of the composition of 
son between doxorubicin transport into cytoplasmic mere- Escherichia coli lipids 
brane vesicles and the transport across the model mem- 
branes composed of the corresponding phospholipids has E. coli strain MRE600, and HDLl l  were grown as 
not yet been made. described above. E. coli HDL11 was grown either in the 
We therefore compared transport of doxorubicin in absence or in the presence of 100 ~M IPTG. Total lipid 
right-side-out cytoplasmic membrane vesicles (ROV) with extracts were prepared from washed E. coli ceils [23] by 
transport of this drug across membranes of large unilamel- extracting the lipids [24] and removing proteins and neutral 
lar vesicles (LUVET) composed of phospholipids i olated lipids on a silica column. Lipids were separated by two 
from the corresponding cells. The bacterium Escherichia dimensional high-performance thin-layer chromatography 
coli was used as a model organism for the following (K iese lge l  60, Merck ,  Germany)  wi th  
reasons: (i) The availability of different mutants allows for chloroform/methanol/ammonia/water (68:28:2:2, v /v)  
extensive in vivo manipulation of the phospholipid compo- in the first dimension and chloroform/methanol/acetic 
sition, whereas uch mutants are not available for cancer acid (65:25:10, v /v)  in the second dimension. Spots were 
cells. (ii) Comparative binding studies of doxorubicin to visualized with I 2 and excised for Pi quantification [25]. 
membranes of LUVET and ROV derived from E. coli The lipid composition of ROV was determined after a 
have already been performed [19]. We developed an assay Bligh and Dyer extraction [24]. 
to measure doxorubicin diffusion in ROV based on a 
method developed for LUVET [8]. Transport of doxoru- 2.4. Preparation of right-side-out cytoplasmic membrane 
bicin across membranes of ROV and LUVET derived from L, esicles (ROV) and large unilamellar uesicles (LUVET) 
several E. coli strains differing in phospholipid composi- with or without enclosed DNA .for transport experiments 
tion was directly compared. 
Preparation of DNA to be enclosed in LUVET and 
ROV was as described [8]. LUVET with or without en- 
2. Materials and methods closed DNA were prepared by the method described by 
Speelmans et al. [8]. In order to enclose DNA in ROV, the 
2.1. Growth of Escherichia coli strains vesicles were freeze-thawed five times in the presence of 
sonicated and extruded DNA. Freezing was performed 
The following Escherichia coli strains were employed: quickly in liquid nitrogen and thawing was performed 
E. coli MRE600 [20] was grown in Luria broth (10 g 1-1 slowly at room temperature. The concentration of protein 
bacto-tryptone (Sigma), 5 g 1-1 yeast extract (Sigma), and was about 15 mg/ml and of DNA 30 mM (on Pi basis) 
10 g 1-1 NaCI). E. coli HDLl l  is a strain in which the during the freeze-thaw steps. Subsequently, the ROV were 
gene encoding phosphatidylglycerolphosphate synthase, washed three times in Hepes buffer (10 mM Hepes, 100 
necessary for the synthesis of phosphatidylglycerol (PG) mM NaC1, 1 mM EGTA, pH 7.4) (40 000 X g, 8 rain, 4°C) 
and cardiolipin (CL), is under control of the lac promoter and treated with DNase (5 mg in a total volume of l ml) in 
[21]. In the presence of the inducer isopropylthiogalacto- the presence of 5 mM MgSO 4 for 15 rain at 37°C. The 
side (IPTG) this strain has a phospholipid composition vesicles were washed three times in Pipes buffer and 
comparable tothe wild type (about 25% negatively charged resuspended in Pipes buffer. Control vesicles without DNA 
phospholipids). In the absence of IPTG the level of nega- were washed three times in Hepes buffer and after the 
tively charged phospholipids i strongly reduced [21]. This DNase treatment, the sample was freeze-thawed three 
strain was grown in LB in the absence or in the presence times. Additional DNase was added and after two freeze- 
of 100 /xM IPTG. The precultures of strain HDLl l  were thaw steps ROV were incubated for 15 min at 37°C in 
supplemented with kanamycin (50 /xg/ml), tetracycline order to remove internal, intrinsic DNA. Subsequently, the 
(10 /~g/ml) and chloramphenicol (20 /zg/ml). control ROV were freeze-thawed, washed and resuspended 
in Pipes buffer. The amount of DNA-P~ is 6-9% of total P~ 
2.2. Preparation of right-side-out cytoplasmic membrane and the amount of 2-keto-3-deoxyoctonate 0.01-0.03 tool/ 
vesicles tool total Pi. The ratio of protein to phospholipid (gram 
protein/mmol lipid-P i) was determined to be 1.3 for 
E. coli cells were grown at 37°C until late logarithmic MRE600, and 1.4 for HDLll  grown in the presence or 
phase (Absorbance at 660 nm 0.6-0.8) as described above, absence of IPTG. 
chilled on ice, and harvested by low-speed centrifugation 
(30 rain, 6400 X g, 4°C). Right-side-out cytoplasmic mem- 2.5. Transport experiments and calculation of the perme- 
brane vesicles (ROV) were prepared and isolated as de- abiliO' coefficient 
scribed [22]. Cytoplasmic membrane vesicles were washed 
in Pipes buffer (10 mM Pipes, 100 mM NaC1, 1 mM Transport of doxorubicin across model membranes in 
EGTA, pH 7.4), frozen and stored in liquid nitrogen, which DNA was enclosed, was determined from the rate of 
242 G. Speelmans et al. / Biochimica et Biophysica Acta 1284 (1996) 240-246 
fluorescence decrease (Exc. 490 nm, Era. 594 nm) in an or without enclosed DNA. Upon addition of DNA-contain- 
Aminco fluorimeter as described [8]. The rate constant, k, ing LUVET a slow decrease in fluorescence of doxoru- 
was calculated as: bicin was observed, which represents transport across the 
k = ( AF/At)/[(Qou t -  Oin)" F° ' f ]  ( s - ' )  membrane (Fig. 1A). Upon addition of Triton X-100, 
fluorescence decreased rapidly to the equilibrium level, 
where AF/At is the initial rate of fluorescence quenching, indicating that internal DNA is immediately available for 
Qout is the quantum yield of the total drug (free + bound) doxorubicin binding. When LUVET without enclosed DNA 
outside the vesicles, Qin is the quantum yield of the total were added a small increase in fluorescence is observed, 
drug in the lumen of the DNA-containing vesicles, and F ° which is relieved upon addition of Triton X-100 (Fig. 1A). 
is the original fluorescence of the drug before addition of This reflects the localization of doxorubicin in the by- 
the vesicles, f is the fraction of external free drug after drophobic environment of the membrane bilayer [10]. The 
addition of the vesicles. These parameters were determined 
as described [8]. F ° and AF were corrected for inner A LUVET 
filtering, light scatter and dilution. The permeability coeffi- TritonX-lO0 
cient was calculated with the formula: ~ 
P = k//([Ltot]" a.  N. 1000) (m/s )  . .~ /~. . .~v~.~ b 
where [Lto t] is the lipid concentration, a is the area per 
lipid molecule, and N is Avogadro's number (6.022 • 1023). 
An area, a, of 3.15 • 10 -19 m 2 per lipid molecule for two 
opposing phospholipid molecules (in a bilayer) was as- a . 
sumed [26], except when CL was present. In that case an ~ ' -~ '~- '~ 
area of 6.0- 10-19 m 2 per opposing CL was assumed. 
Permeability coefficients pecific for uncharged rug, 
pO, were calculated using the formula: a 
P°=e(1  + 10 (pK~'-pH)) (m/s )  
Typically, the transport experiments were performed 
with 200 I~M LUVET-P i or 40 /zg ROV protein/ml, pH 
7.4, at 37°C, unless stated otherwise. B Rov 
~, TritonX-1 O0 
2.6. Other methods ~ 
Pi was assayed by the method of Rouser [25]. Protein ~ . . ~  b 
was determined as described [27] using bovine serum 
albumin as a standard. 
2.7. Materials ~ 
Doxorubicin (Pharmachemie, Haarlem, The Nether- 
lands) was shown to be pure by high-performance thin-layer L 
liquid chromatography and dissolved just before use. DNA ~-~ a 
(Type I from calf thymus), DNase I (type DN-25 from 
bovine pancreas), and RNase were obtained from Sigma, ~5O/o F ~r~in 
St. Louis, USA. Lysozyme was obtained from Boehringer, 
Mannheim, Germany. Fig. 1. Doxorubicin transport into LUVET and ROV. Fluorescence traces 
of 1 ~M doxorubicin are shown against ime. Upon addition of doxoru- 
bicin to Pipes buffer (pH 7.4) an immediate fluorescence is observed 
3. Results (excitation 490 nm, emission 594 nm). (A) As indicated by the first 
arrow, LUVET (200 /xM lipid-Pi), composed of phospholipids i olated 
from E. coli HDLl l  grown in the presence of 100 /xM IPTG, are added 
3.1. Transport of doxorubicin into large unilamellar vesi- which contained DNA (trace a) or which did not contain DNA (trace b). 
cIes (LUVET) composed of phospholipids and into right- (B) As indicated by the first arrow, ROV (40 /xg protein/ml, represent- 
side-out cytoplasmic membrane vesicles (ROV) derived ing 28.6 /xM lipid-Pi), derived from E. coli HDLl l  grown in the 
from Escherichia coli presence of IPTG, are added which contained DNA (trace a) or which did 
not contain DNA (trace b). Triton X-100 is added to a final concentration 
of 0.05% (v/v)  as indicated by the second arrows, in order to permeabi- 
Large unilamellar vesicles (LUVET) of  E. eoli phos- lize the membranes. The temperature was 37°C, F is expressed as 
pholipids of a wild-type composition were prepared with percentage fluorescence of I /xM free doxorubicin. 
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absence of this small fluorescence increase in DNA-con- was higher with ROV, due to the lower amount of lipids 
taining LUVET is due to small amounts of external DNA present during transport experiments (Table 1); ROV were 
which could not be removed by the DNase treatment, added in lower concentrations to minimize the effect of 
From these traces transport parameters were measured and light scatter and inner filtering. The permeability coeffi- 
permeability coefficients (p0) were calculated (Table 1). cients in ROV were 2-3-times higher than the correspond- 
Although some intrinsic DNA remains inside the ROV ing permeability coefficients in LUVET. 
after the isolation procedure, differences between external 
and internal quantum yield are small and permeability 
3.2. Effect of drug concentration, verapamil, Mg 2 +, and coefficients can be calculated less accurately. In order to 
measure transport of doxorubicin across membranes of pH on transport of doxorubicin across membranes of 
right-side-out cytoplasmic membrane vesicles (ROV) with LUVET and ROV 
a similar assay as for LUVET, a method had to be 
developed for the incorporation of high concentrations of It was investigated whether doxorubicin transport in 
exogenous DNA in ROV. Enclosure of exogenous DNA ROV involves only passive diffusion across the phospho- 
was achieved if DNA, fragmented by sonication and extru- lipid bilayer or whether carrier facilitated iffusion is also 
sion, was present during freeze-thawing the ROV. After 3 present. First the effect of verapamil, a specific inhibitor 
to 5 freeze-thaw steps maximal incorporation was ob- (in the /xM range)of P-glycoprotein mediated transport of 
tained. Most efficient entrapment was observed if the doxorubicin, but also an inhibitor of bacterial drug effiux 
freezing was performed quickly (liquid N 2) and thawing systems [29-31], was examined. Verapamil did not inhibit 
slowly (room temperature or on ice). Assuming an internal transport up to concentrations of 10 /xM in both LUVET 
volume for ROV of 3 p,1/mg protein [28], enclosure and ROV (data not shown). Higher concentrations were 
efficiencies ranged from 50 to 95%. In control ROV not used, since effects on passive diffusion in LUVET and 
intrinsic DNA had to be removed in order to obtain ROV may occur [10]. 
fluorescence traces without a background ecrease, and Subsequently, the influence of the concentration of 
this was achieved by enclosing DNase in ROV by freeze- doxorubicin on transport rate was determined for LUVET 
thawing (see Section 2). In Fig. 1B traces representative and ROV in a range from 0.5 to 4 /xM. The effect of 
for transport of doxorubicin across membranes of ROV doxorubicin concentration on initial transport rate was 
with a wild-type phospholipid composition are shown. A comparable in LUVET and ROV, yielding apparent K m 
small and immediate decrease in fluorescence of doxoru- values of 5 _ 2 and 4 ___ 2 /xM, respectively. Saturation of 
bicin is observed in control ROV and in ROV with en- drug transport might become more clear at high drug 
closed DNA. However, only in ROV with enclosed DNA a concentrations, but the fluorescence assay does not allow 
slow fluorescence decrease is observed, which represents the use of high drug concentrations. The permeability 
transport of doxorubicin across the membrane. Upon addi- coefficients decreased with increasing drug/phospholipid 
tion of Triton X-100, internal DNA is immediately avail- ratio as well as for LUVET as for ROV (data not shown). 
able for doxorubicin binding. This assay was used to This apparent saturation could be due to self-aggregation 
obtain doxorubicin transport and parameters, uch as inter- of doxorubicin at higher drug concentrations or to the 
hal and external quantum yield, necessary to calculate the effect of a higher membrane disturbance when more drug 
p0 values. These parameters were comparable for ROV is inserted into the membrane, which inhibits passive 
and LUVET (Table 1 ), except hat the fraction of free drug diffusion [8]. 
Divalent cations such as Mg 2+ increase the order of 
lipid bilayers, p0 decreases with increasing Mg 2+ concert- 
Table 1 trations in all membrane preparations tested (data not 
Transport parameters forpassive diffusion of doxorubicin across mere- shown). Addition of 5 mM Mg 2 + decreased the permeabil- 
branes of LUVET and ROV derived from E. coli HDL1 ! grown in the ity coefficient about 45 + 4% in LUVET and about 60 __ 
presence of 100 p.M IPTG 3% in ROV. 
Model system LUVET ROV Finally, passive diffusion across the bilayer is supposed 
p0 (k~m/s) a 1.5 _+ 0.1 4.2 + 0.6 to involve the uncharged form of doxorubicin only, whereas 
Qout b 1.02 1.06 enzyme-mediated transport most likely involves positively 
Q~,, L- 0.07 0.16 charged doxorubicin, because the substrate spectrum of 
f d 0.76 0.89 
drug efflux systems includes permanently positively 
a The permeability coefficient for uncharged oxorubicin at 37°C. n = charged drugs [29-31]. Transport experiments were per- 
6-12. formed at different pH values and permeability coefficients 
b Quantum yield of doxorubicin outside and at the outer leaflet of the were calculated for total doxorubicin, charged plus un- 
LUVET or ROV. 
c Quantum yield of doxorubicin inside and at the inner leaflet of the charged (pK a of doxorubicin 8.3). The results show that 
LUVET and ROV with enclosed DNA. the pH dependency of doxorubicin diffusion across mem- 
Fraction of free drug during transport experiments, branes of LUVET and ROV is comparable, indicating that 
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Fig. 2. Effect of pH on transport of doxornbicin into LUVET and ROV, 
The external pH was varied and permeability coefficients were calculated 
for the total amount of doxorubicin (charged plus uncharged). (0 )  -~- 
LUVET composed of phospholipids i olated from E. coli HDL11 grown "E 
in the presence of IPTG. (©) ROV derived from E. coli HDL11 grown ~ 1 
in the presence of IPTG. n = 4-6. ~_ 
mainly passive diffusion of neutral doxorubicin across the 
phospholipid bilayer is involved (Fig. 2). '~.1 ' ' ' 
3.2 3.3 3.4 3,s 
3.3. Effect of phospholipid composition on passive diffu- 1000/K 
sion o f  doxorubicin across membranes of  LUVET and Fig. 4. Arrhenius plot of passive diffusion of doxorubicin. Permeability 
ROV coefficients were determined as described in Section 2. A: Permeability 
coefficients of doxorubicin transport into LUVET. B: Permeability coeffi- 
Phospholipids were extracted from E. coli MRE600 cients of doxorubicin transport into ROV. (©) E. coli MRE600, (D)  E. 
eoli HDLI1 grown in the presence of IPTG, (11) E. coU HDLl l  grown 
and HDLl l ,  grown in the absence or in the presence of in the absence ofIPTG. n = 6-12. 
100 /xM IPTG. The headgroup composition of the phos- 
pholipid extracts was determined and found to be similar 
the strains is shown in Fig. 3. The fraction of bound drug to those described in literature [19]. The amount of nega- 
in transport experiments increased with increasing amount tively charged phospholipids (sum of CL, PG and PA) of 
of negatively charged phospholipids (data not shown). The 
permeability coefficient for LUVET composed of phos- 
5 50 pholipids from the wild-type MRE600, and HDL11 grown 
in the presence of IPTG is similar. Permeability is some- 
4 40 ~ what lower in LUVET composed of lipids of HDLl l  
grown in the absence of IPTG (Fig. 3). 
~- ROV were isolated from the E. coli strains and the 
3 30  O 
x: amount of negatively charged phospholipids was similar to 
~" the phospholipid composition of the corresponding LU- 
St. 2 20 ~. VET. Permeability coefficients of doxorubicin transport in 
._o,. ROV were 2-3-times higher than those obtained for LU- 
1 lO  o • ~ VET, but the effect of phospholipid composition was the < 
same (with a standard deviation of less than 0.05) as 
0 o observed for LUVET. p0 obtained was highest for strain 
MRE600 HDL11 + IPTG HDL11 - IPTG HDL11 grown in the presence of IPTG, and for MRE600, 
s t ra in  and lowest in HDL11 grown in the absence of IPTG (Fig. 
Fig. 3. Permeability coefficients at 37°C of doxorubicin across model 3). 
membrane systems. Membranes were composed of LUVET (black) or 
ROV (arced bars) derived from E. coli strain MRE600, and HDLl l  3.4, Activation energies of passive diffusion of doxorubicin 
grown in the presence or absence of IPTG, n=6-12 .  Permeability across LUVET and ROV 
coefficients were determined as described in Section 2. White bars: The 
percentage of anionic phospholipids in the membranes for ROV and 
LUVET. The phospholipid composition of ROV and LUVET prepara- The temperature dependence of passive diffusion of 
tions was the same, with a standard eviation of less than 0.05. doxorubicin was determined in LUVET and ROV in the 
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range from 15 to 37°C for LUVET and from 20 to 42°C relevant system, such as cytoplasmic membranes, despite 
for ROV. Arrhenius plots are shown in Fig. 4. The activa- the absence of proteins and the absence of membrane 
tion energies were corrected for temperature dependent asymmetry. 
changes in buffer pH and pK a of doxorubicin [9]. For all The effect of phospholipid composition on the perme- 
LUVET preparations the activation energy is comparable; ability coefficient p0 of doxorubicin was the same in 
79 kJ/mol for MRE600, 88 kJ/mol for HDLl l  grown LUVET as in ROV. However, a comparison in doxoru- 
with 1PTG, and 94 kJ/mol for HDL11 grown without bicin diffusion in LUVET and ROV prepared from lipids 
IPTG (Fig. 4A). Similar values for activation energies of extracted from E. coli strains differing in phospholipid 
doxorubicin transport were observed in LUVET composed composition did not show the relationship between the 
of synthetic lipids, such as DOPC and DOPG/DOPC amount of negatively charged lipids and passive diflusion 
mixtures (data not shown). The interaction of doxorubicin observed previously with LUVET composed of synthetic 
with negatively charged phospholipids, i.e. binding of dioleoyl lipids representative for the eukaryotic plasma 
positively charged doxorubicin to the negatively charged membrane [8,10]. In doxorubicin transport across bilayers 
phospholipid headgroups and penetration into the hy- of E. coli phospholipids the membrane order probably 
drophobic part of the membrane, has therefore no effect on plays a more important role than binding and insertion of 
the mechanism of passive diffusion, or at least on the most doxorubicin. Membranes composed of pure phos- 
temperature d pendent s ep of this process, phatidylethanolamine (PE) isolated from E. coli have a 
The activation energy of doxorubicin diffusion is almost higher membrane order than wild-type phospholipids, con- 
2-fold lower in ROV; 45 kJ/mol for HDL11 grown taining 75% PE and 25% negatively charged phospholipids 
without IPTG, 50 kJ/mol for MRE600, and 56 kJ/mol for [23] and this is in accordance with the lower p0 observed 
HDLII grown with IPTG (Fig. 4B). Also in ROV no in LUVET and ROV from HDLl l  grown without IPTG, 
effect of the phospholipid headgroup composition on the because these membranes contain a higher percentage PE 
activation energy was observed, and lower percentage negatively charged phospholipids. 
Membrane order also plays a role in the comparable 
effects of Mg 2+ on p0 in ROV and LUVET; in the 
4. Discussion presence of this divalent cation membrane order is in- 
creased [32], resulting in a decreased p0. MgZ+ has an 
Mechanistic and kinetic studies of passive diffusion of effects on the surface charge resulting in a lower binding 
doxorubicin across the lipid bilayer have either been per- of doxorubicin to the membranes (data not shown), but 
formed in vesicles composed of pure (phospho)lipids or in these effects are taken into account in the calculation of 
intact cells. In order to directly compare passive diffusion the p0 and are small compared by the effect on membrane 
across membranes composed of pure phospholipids and order. 
vesicles prepared from biomembranes a transport assay The permeability coefficients p0 for doxorubicin ob- 
was developed, based on the decrease of doxorubicin served with ROV were 2-3-fold higher than those ob- 
fluorescence upon binding to DNA enclosed in the vesi- served with LUVET. Again, this can be explained by an 
cles. DNA was enclosed in large unilamellar vesicles effect on membrane order: In E. coli spheroplasts the 
(LUVET) by preparing the vesicles in the presence of quadrupolar splitting in the 2H-NMR spectrum of [ l l , l l -  
DNA and in right-side-out cytoplasmic membrane vesicles ?H2]oleoyMabeled phospholipids i lower than in LUVET 
(ROV) by applying freeze-thaw steps in the presence of composed of the isolated phospholipids, namely 7.2 and 
DNA. The membrane systems employed were derived 10.9 kHz at 20°C, respectively [33]. This demonstrates that 
from Escherichia coli. in protein containing biomembranes the acyl chains are 
The most likely mechanism of doxorubicin transport less ordered than in the protein-free system. From the 
present in LUVET and ROV is passive diffusion across the previously observed inverse relationship between the 
phospholipid bilayer, because (i) transport rate increased quadrupolar splitting and the permeability coefficient p0 
with increasing pH to the same extent in LUVET and of doxorubicin a factor 2.3 difference in p0 at these two 
ROV, indicating that mainly uncharged oxorubicin was values of quadrupolar splitting would be expected [8] 
transported, (ii) verapamil, an inhibitor of enzymes mediat- which is close to the experimentally determined value. 
ing doxorubicin and daunorubicin transport [29-31], did A difference in temperature d pendence of doxorubicin 
not have an inhibitory effect in ROV, and (iii) a compara- permeation in LUVET and ROV exists. In LUVET the 
ble effect of increasing drug concentration on transport average activation energy is about 87 kJ/mol, which 
velocity was observed in ROV and LUVET. Furthermore, corresponds to values reported in literature. 117 kJ/mol 
after loading of EDTA treated E. coli cells with doxoru- [5] and 92 kJ/mol, calculated from [9]. The activation 
bicin, doxorubicin efflux was not observed upon addition energy for doxorubicin diffusion in ROV is about 2-times 
of glucose (unpublished). Therefore, we conclude that for lower than in LUVET. Such a result could be interpreted 
passive diffusion the results obtained in model membranes, as a difference in transport mechanism. However, facili- 
such as LUVET, are representative for more biologically tated diffusion in the ROV model system is not very likely 
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(see above). In ROV doxorubicin diffusion could occur via [8] Speelmans, G., Staffhorst, R.W.H.M., De Kruijff, B. and De Wolf, 
the protein/lipid interface, which might take place with a F.A. (1994) Biochemistry 33, 13761-13768. 
different activation energy. An alternative xplanation is [9] Fr6zard, F. and Garnier-Suillerot A. (1991) Biochemistry 30, 5038- 
5043. 
that the membrane order increases much less with decreas- [10] Speelmans, G,, Staffhorst, R.W.H.M., De Wolf, F.A. and De Krui- 
ing temperature in the presence of membrane proteins, jff, B. (1995)Biochim. Biophys. Acta 1238, 137-146. 
Indeed, in spheroplasts of E. coli the membrane order [11] Praet, M., Defrise-Quertain, F. and Ruysschaert, J.M. (1993) 
seems to increase about 1.5-2-times less with decreasing Biochym. Biophys. Acta 1148, 342-350. 
temperature than the membrane order of pure E. coli [12] Andreoni, A. Colasanti, A., Kisslinger, A., Mastrocinque, M., Ric- 
cio, P. and Roberti, G. (1994) J. Biochem. Biophys. Methods 28, 
phospholipid extracts [33]. Since the rate of passive diffu- 53-68. 
sion is directly influenced by the membrane order [8] this [13] Borell, M.-N., Fiallo, M., Priebe, W. and Garnier-Suillerot. A. 
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